A novel approach to maintain gut mucosal integrity using an oral enzyme supplement

Annals of Surgery

Volumn 260, Issue 4, 2014, Pages 706-715

  Hamarneh, Sulaiman R ^a   Mohamed, Mussa M Rafat ^a   Economopoulos, Konstantinos P ^a   Morrison, Sara A ^a   Phupitakphol, Tanit ^a   Tantillo, Tyler J ^a   Gul, Sarah S ^a   Gharedaghi, Mohammad Hadi ^a   Tao, Qingsong ^a   Kaliannan, Kanakaraju ^a   Narisawa, Sonoko ^b   Millán, José L ^b   Van Der Wilden, Gwendolyn M ^a   Fagenholz, Peter J ^a   Malo, Madhu S ^a   Hodin, Richard A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Enteral starvation; ICU patient; Intestinal alkaline phosphatase; Intestinal permeability; Tight junctions; Total parenteral nutrition

Indexed keywords

ALKALINE PHOSPHATASE; CLAUDIN 1; INTESTINAL ALKALINE PHOSPHATASE; PROTEIN ZO1; PROTEIN ZO3; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; ZONULA OCCLUDENS PROTEIN; TIGHT JUNCTION PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENTERIC FEEDING; ENZYME REPLACEMENT; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; TREATMENT OUTCOME; ANIMAL; ARTICLE; CRITICAL ILLNESS; DIET SUPPLEMENTATION; ENZYMOLOGY; ILEUM; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; JEJUNUM; METABOLISM; ORAL DRUG ADMINISTRATION; PERMEABILITY; STARVATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; HUMANS; ILEUM; INFLAMMATION; INTESTINAL MUCOSA; JEJUNUM; MICE; PERMEABILITY; STARVATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIGHT JUNCTION PROTEINS; UP-REGULATION;

EID: 84908322981     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000916     Document Type: Conference Paper

References (39)

1. Merrell RC. The abdomen as source of sepsis in critically ill patients. Crit Care Clin. 1995;11:255-272.
2. Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med. 1998;158:444-451.
3. Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med. 2001;29:2264-2270.
4. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg. 1992;216:172-183.
5. Doig GS, Heighes PT, Simpson F, et al. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med. 2009;35:2018-2027.
6. Buchman AL, Moukarzel AA, Bhuta S, et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr. 1995;19:453-460.
7. Alverdy JC, Aoys E, Moss GS. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery. 1988;104:185-190.
8. Hernandez G, Velasco N, Wainstein C, et al. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care. 1999;14: 73-77.
9. Stechmiller JK, Treloar D, Allen N. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care. 1997;6:204-209.
10. Harris CE, Griffiths RD, Freestone N, et al. Intestinal permeability in the critically ill. Intensive Care Med. 1992;18:38-41.
11. Kane TD, Alexander JW, Johannigman JA. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann Surg. 1998;227:1-9.
12. Ivanov AI. Structure and regulation of intestinal epithelial tight junctions: current concepts and unanswered questions. Adv Exp Med Biol. 2012;763:132-148.
13. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799-809.
14. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631-659.
15. Miyasaka EA, Feng Y, Poroyko V, et al. Total parenteral nutrition-associated lamina propria inflammation inmice ismediated by a MyD88-dependent mechanism. J Immunol. 2013;190:6607-6615.
16. Sussman NL, Eliakim R, Rubin D, et al. Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes.AmJ Physiol. 1989;257:G14-G23.
17. Malo MS,Alam SN, Mostafa G, et al. Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut. 2010;59:1476-1484.
18. Chen KT, Malo MS, Beasley-Topliffe LK, et al. A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Dig Dis Sci. 2011;56:1020-1027.
19. Moss WW, Webster WA. A numerical taxonomic study of a group of selected strongylates (Nematoda). Syst Zool. 1969;18:423-443.
20. Chen KT, Malo MS, Moss AK, et al. Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastrointest Liver Physiol. 2010;299:G467-G475.
21. Ramasamy S, Nguyen DD, Eston MA, et al. Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm Bowel Dis. 2011;17:532-542.
22. Kaliannan K, Hamarneh SR, Economopoulos KP, et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A. 2013;110:7003-7008.
23. Hodin RA, Graham JR, Meng S, et al. Temporal pattern of rat small intestinal gene expression with refeeding. Am J Physiol. 1994;266:G83-G89.
24. Goldberg RF, AustenWG, Jr, Zhang X, et al. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A. 2008;105:3551-3556.
25. Narisawa S, Huang L, Iwasaki A, et al. Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol. 2003;23:7525-7530.
26. Moss AK, Hamarneh SR,Mohamed MM, et al. Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate. Am J Physiol Gastrointest Liver Physiol. 2013;304:G597-G604.
27. Wang HB,Wang PY,Wang X, et al. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012;57:3126-3135.
28. Al-Sadi R, Khatib K, Guo S, et al. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1054-G1064.
29. Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004;286:G367-G376.
30. Al-Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol. 2007;178:4641-4649.
31. Guo S, Al-Sadi R, Said HM, et al. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182:375-387.
32. Feng Y, Teitelbaum DH. Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am J Physiol Gastrointest Liver Physiol. 2012;302:G236-G249.
33. Ikeda T, Hiromatsu K, Hotokezaka M, et al. Up-regulation of intestinal Toll-Like receptors and cytokines expressions change after TPN administration and a lack of enteral feeding. J Surg Res. 2010;160:244-252.
34. Feng Y, Teitelbaum DH. Tumour necrosis factor-induced loss of intestinal barrier function requires TNFR1 and TNFR2 signaling in a mouse model of total parenteral nutrition. J Physiol. 2013;591:3709-3723.
35. Beumer C,WulferinkM, Raaben W, et al. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J Pharmacol Exp Ther. 2003;307:737-744.
36. Feng Y, Ralls MW, Xiao W, et al. Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann N Y Acad Sci. 2012;1258:71-77.
37. Lalles JP. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis andmodulation by diet. Nutr Rev. 2010;68:323-332.
38. Peterson CY, Costantini TW, Loomis WH, et al. Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury. Surg Infect (Larchmt). 2010;11:137-144.
39. Lukas M, Drastich P, Konecny M, et al. Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis. 2010;1180-1186.